Fennec Pharmaceuticals FENC
NASDAQ FENC
$12.39 -0.16 (-1.28%)
As of: Sep 4, 2026 · 3:59 PM EDT

Fennec Pharmaceuticals (FENC) Net Shares Issued and Repurchased (2018 - 2026)

Analysis

Fennec Pharmaceuticals (FENC) Net Shares Issued and Repurchased (2018 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued and Repurchased (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Fennec Pharmaceuticals 432.85 Mn 391.60 Mn 17.15 Mn 31,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 31,000.00
Dec 31, 2025 259,000.00
Sep 30, 2025 31,000.00
Jun 30, 2025 45,000.00
Mar 31, 2025 123,000.00
Dec 31, 2024 426,000.00
Sep 30, 2024 276,000.00
Jun 30, 2024 100,000.00
Dec 31, 2023 400,000.00
Sep 30, 2023 160,000.00
Jun 30, 2023 175,000.00
Mar 31, 2023 38,000.00
Dec 31, 2022 462,000.00
Sep 30, 2022 30,000.00
Jun 30, 2022 8,000.00
Mar 31, 2022 382,000.00
Dec 31, 2021 94,000.00
Jun 30, 2021 50,000.00
Dec 31, 2019 2.11 Mn
Dec 31, 2018 648,000.00